genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
DNA
X and Y: Synthorx Expands the Genetic Code to Create Optimized…
Cancer
Set Phase Separation to Stun
Gene Therapy
A New Vision for Gene Therapy
OMICs
Can Encodia Become the Illumina of Proteomics?
Alzheimers
Cognition Thinks It Has an Alzheimer’s Blockbuster
News
CAR T-Cells
T Cells with Upgraded Molecular Computers Can Sort Out Tumor Targets
Cancer
Dexamethasone May Be Detrimental to Immunotherapy in Glioblastoma Patients
News
Post-Myocardial Infarction Treatment Shows Promise in Mice
Transcriptome
Robotic Culture System Enables Mechanistic View of How Bacteria Evolve Drug…
ALS
Steering Stem Cells to Repair Sites Using Inflammo-Free Inflammo-Attraction
Insights
All
Trends for 2020
Drug Discovery
Multi-Attribute Methods Supporting Quality Assessments of Therapeutic Proteins
Bioprocessing
COVID Driving Biopharma to Embrace Digital Tech Faster
Bioprocessing
Boosting Capabilities in Gene and Cell Therapy Bioprocessing
Bioprocessing
Bioprocessing’s Potential Impact on Patients
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
CAR T-Cells
T Cells with Upgraded Molecular Computers Can Sort Out Tumor Targets
Cancer
Dexamethasone May Be Detrimental to Immunotherapy in Glioblastoma Patients
Drug Discovery
Multi-Attribute Methods Supporting Quality Assessments of Therapeutic Proteins
Point of View
An Autologous Stem Cell-Based Therapy for Parkinson’s Disease
Magazine
All
Supplement
November 2020 Vol. 40 No. 11
With Synthetic Biology Nature Is All Business
Biobanking
Biobanks Are Becoming Data Banks in the Era of Personalized Medicine
Biobanking
Cryopreservation to Improve Cell Manufacturing and Biobanking
Biobanking
Enabling Scientific Discovery and Healthcare with Biobanks
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Viral Vectors
AAV (Adeno-associated virus)
AAV (Adeno-associated virus)
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
On Demand Webinars
A Conversation with Jennifer Doudna,2020 Nobel Laureate
AAV (Adeno-associated virus)
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech Eye 14,000 More Participants
AAV (Adeno-associated virus)
Ophthotech Licenses Rights to Develop AAV Gene Therapies for Best Disease from Penn, U. Florida
On Demand Webinars
Scalable Plasmid-Free AAV Manufacturing
On Demand Webinars
Scalable Plasmid-Free AAV Manufacturing
AAV (Adeno-associated virus)
AAV-Based Gene Therapy Boosted by Curbed Immune Response
AAV (Adeno-associated virus)
AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer’s, Neurodegenerative Diseases
On Demand Webinars
A Conversation with Jennifer Doudna,2020 Nobel Laureate
AAV (Adeno-associated virus)
AstraZeneca-Oxford COVID-19 Vaccine Shows Positive Phase II Results
AAV (Adeno-associated virus)
Redefining AAV Manufacturing: The Time Is Now
AAV (Adeno-associated virus)
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech...
AAV (Adeno-associated virus)
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19...
AAV (Adeno-associated virus)
AstraZeneca Pauses Phase III COVID-19 Vaccine Trial, Citing “Potentially Unexplained Illness”
AAV (Adeno-associated virus)
Next-Generation Light Scattering: Determining AAV Titer with Multi-Angle Dynamic Light Scattering
1
2
3
Page 1 of 3
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
